SGLT2 Inhibitors in Diabetes Mellitus Treatment

E-ISSN： 1876-1038|12|1|8-18

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.12, Iss.1, 2017-01, pp. : 8-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Jardiance: the latest SGLT2 for the treatment of type 2 diabetes

PRESCRIBER, Vol. 26, Iss. 11, 2015-06 ,pp. : 30-31

John Wiley & Sons Inc

Access to resources Recommend Favorite

The potential role of sodium glucose co‐transporter 2 inhibitors in the early treatment of type 2 diabetes mellitus

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 10, 2015-10 ,pp. : 1071-1087

John Wiley & Sons Inc

Access to resources Recommend Favorite

The potential role of sodium glucose co‐transporter 2 inhibitors in the early treatment of type 2 diabetes mellitus

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 1368-5031, Iss. 10, 2015-10 ,pp. : 1071-1087

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 10, 2015-10 ,pp. : 999-1024

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment intensification in type 2 diabetes mellitus and obesity

By Zawiejska Agnieszka McAleese Jane Yemparala Prasad Taheri Shahrad

British Journal of General Practice, Vol. 63, Iss. 609, 2013-04 ,pp. : 182-182

Royal College of General Practitioners

Access to resources Recommend Favorite